Syncom Formulations (India)

Syncom Formulations (India) EBITDA per Share

The EBITDA per Share of Syncom Formulations (India) (SYNCOMF.NS) as of Oct 17, 2026 is 0.75 INR. In the previous year, EBITDA per Share was 0.76 INR — a change of -0.93% (lower).

EBITDA per Share

0.75INR

YoY

-0.93%

Last updated:

EBITDA per Share of Syncom Formulations (India) is 2026 0.75 INR. EBITDA per Share of Syncom Formulations (India) was 2025 0.76 INR. It decreases by -0.93% lower compared to the previous year.

The Syncom Formulations (India) EBITDA per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA per Share
Date
EBITDA per Share
Jan 1, 2019
0.09 INR
Jan 1, 2020
0.16 INR
Jan 1, 2021
0.39 INR
Jan 1, 2022
0.20 INR
Jan 1, 2023
0.36 INR
Jan 1, 2024
0.28 INR
Jan 1, 2025
0.76 INR
Jan 1, 2026
0.75 INR
The Syncom Formulations (India) EBITDA per Share history
YEAREBITDA per ShareYoY
0.75INR-0.93%
0.76INR+170.63%
0.28INR-22.56%
0.36INR+82.64%
0.20INR-49.60%
0.39INR+140.22%
0.16INR+83.39%
0.09INR-14.26%
0.10INR-55.91%
0.24INR+31.85%
0.18INR+4.92%
0.17INR+4.03%
0.16INR—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Syncom Formulations (India) Stock analysis

What does Syncom Formulations (India) do? Syncom Formulations (India) Ltd., headquartered in Indore, Madhya Pradesh, is a pharmaceutical company operating in the Health Care sector. It develops, manufactures, and markets a wide range of healthcare products including tablets, capsules, injections, ophthalmic preparations, and nutritional formulations. The company employs 799 full-time staff and serves domestic markets with product lines such as Cratus Life Care and Cratus Right Nutrition. Its portfolio includes antibiotics like Ciprofloxacin and Ceftriaxone for various medical applications. Syncom Formulations (India) is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Syncom Formulations (India) stock

EBITDA per Share of Syncom Formulations (India) is 0.75 INR in 2026.

EBITDA per Share of Syncom Formulations (India) changed from 0.76 INR to 0.75 INR, representing a -0.93% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBITDA per Share Syncom Formulations (India) since 2006 – with annual values, charts, and detailed analysis.

EBITDA per share divides EBITDA by shares outstanding, showing the operating cash earnings allocated to each share before depreciation and financing effects.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Income Statement — Syncom Formulations (India)

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — Syncom Formulations (India)